Randomized controlled clinical trial to evaluate the efficacy of Lauhadi Modaka in the management of Pandu(Iron deficiency Anaemia).
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 92
- 试验地点
- 1
- 主要终点
- Subjective criteria:-
研究概览
简要总结
Iron deficiency anaemia is one of the common deficiency disease.In anaemia haemoglobin concentration falls below the accepted range depending upon age and gender.There are several types of anaemia amongst them iron deficiency anaemia is very common. Due to less dietary intake ,poor availability of iron, chronic blood loss, its prevalence is high.In Panduroga all three doshas are vitiated,but there is predominance of Pitta dosha,due to that Panduroga is pitta pradhan vyadhi.Due to excessive intake of oily,sour,hot,salty,pungent food, excessive excercise, daytime sleeping and emotions like krodha,bhay, shok pitta gets vitiated.Anaemia is public health problem that affects populations in both rich and poor countries .Globally anaemia affects 1.62 billion people, which corresponds to 24.8% of the population.Ayurveda has explained Panduroga in detail with its type, causes, symptoms and different aspects of treatment including shoshana, shamana, with various drug formulations and without sideeffectsalso they are economically affordable. Keeping all these factors in mind .Ayurvedic treatment for this disease may be more effective than modern medicine Vangsena samhita described “Lauhadi Modaka†in the management of panduroga ,which has the property of Pitta shamana.The ingredients of Lauhadi Modaka are cheap and easily available.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients having symptoms such as Daurbalya,Akshikutshotha,Panduta Pindikodweshtan, Hrutspandana.
- •Patient having Hb% more than 7 and less than 12gm/dl in females.
- •more than 8 & less than 13gm/dl in males.
排除标准
- •1.Pregnancy induced Anaemia.
- •Patients present with known case of Sickle cell Anemia, Megaloblastic Anemia, Aplastic Anemia, Pernicious Anemia.
- •3 .Patients present with known case of any bleeding disorders, Thrombocytopenia, Hemorrhoids, Thalesemia.
结局指标
主要结局
Subjective criteria:-
时间窗: 15th,30th,45 th day
1.Daurbalya will reduce
时间窗: 15th,30th,45 th day
2.Akshikutashotha will reduce
时间窗: 15th,30th,45 th day
3.Panduta
时间窗: 15th,30th,45 th day
4.Pindikodweshtan will reduce
时间窗: 15th,30th,45 th day
5.Hrutaspandana will reduce
时间窗: 15th,30th,45 th day
次要结局
- Hb%(MCH)
研究者
DrKumud bahurupi
C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431011
